ASH 2024: MPN Research Highlights with Dr. Angela Fleischman Discover the latest breakthroughs in Myeloproliferative Neoplasm (MPN) research from ASH 2024 with insights from MPN expert Dr. Angela Fleischman. This year’s conference unveiled progress in understanding and treating MPNs, including Polycythemia Vera (PV), Myelofibrosis (MF), and Essential Thrombocythemia (ET). In this interview, Dr. Fleischman discusses […]
by David Wallace 2024 Patients Are Asking, Episode 2 In this MPN expert interview, Dr. Gaby Hobbs shares her expertise on the various treatment options for Polycythemia Vera (PV). She explains first-line therapies, including phlebotomy, hydroxyurea, interferon (Besremi), Jakafi and highlights the importance of individualized treatment based on patient-specific factors. Watch the full interview to […]
by David Wallace 2024 Patients Are Asking, Episode 1 In our ongoing effort to provide the latest insights and resources for the MPN community, we’re excited to share an informative video on tailoring JAK inhibitor treatment strategies for myelofibrosis. Our interview with MPN expert, Dr. Lucia Masarova covers important aspects of JAK inhibitors, their role […]
Optimizing MPN Patient Outcomes: The Holistic Approach by David Wallace Join us as we sit down with renowned MPN expert, Dr. Angela Fleischman, for an enlightening conversation about living optimally with Myeloproliferative Neoplasms. Dive deep into actionable strategies for managing myelofibrosis and discover tips to enhance your journey with MPNs. Your host, David Wallace, founder […]
by David Wallace Patients Are Asking – Episode 1 In this MPN specialist interview with Dr. Ghaith Abu-Zeinah, we learn what the term “disease modification” means. We discuss promising late-stage clinical trials and the importance of tracking your symptoms to discuss with your physician. David Wallace, PV Reporter, is your host and patient advocate. […]
by David Wallace Patients are Asking – MPN Specialist Dr. Srdan Verstovsek – Episode 3 of 3 Interview with MPN expert, Dr. Srdan Verstovsek from ASH 2022. Learn about an exciting new anti-mutant calreticulin (CALR) targeted monoclonal antibody that may lead to a molecular response in MF and ET. What were some of the highlights […]
by David Wallace Patients are Asking – Episode 2 of 3 In this interview with MPN expert, Dr. Angela Fleischman, we discuss the latest treatments for myelofibrosis (MF) and when a clinical trial should be considered. Research has linked MPNs to a pre-disposition to auto-immune disorders such as Lupus, Crohn’s disease and Psoriasis just to […]
by David Wallace Patients are Asking – MPN Specialist Dr. Michael Grunwald, from Levine Cancer Institute discusses new medications for myeloproliferative neoplasms Episode 1 of 3 Dr. Grunwald also provides insight into how to get a referral to see an MPN expert. Featuring: Dr. Michael Grunwald Thank you to our Sponsors
New FDA Approved Treatment for Polycythemia Vera Patients are Asking – MPN ExpertDr. Abu-Zeinah discussesRopeginterferon, FDA ApprovedTreatment for Polycythemia Vera Episode 3 of 3 Ropeginterferon / BESREMi was recently approved by the FDA to treat Polycythemia Vera. Patients are asking: Should I switch from Pegasys to the new FDA approved Ropeginterferon? How might Ropeginterferon change […]
by Lou Ann Donovan We all enjoy getting together with friends and attending family gatherings from time to time. Such occasions give us an opportunity to catch up, share ideas, and even lend support to each other. Social connections like these also influence our health and longevity the same as our diet, sleep, and exercise. […]
Site by: Kaleidoscopic
